Zydus receives final approval for Desvenlafaxine Extended Release Tablets
From USFDA
Zydus Cadila has received the final approval from USFDA to market Desvenlafaxine Extended Release Tablets, 50 mg and 100 mg. The drug is used to treat major depression and will be manufactured at the group's formulations manufacturing facility at Moraiya, Ahmedabad.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content